Searchable abstracts of presentations at key conferences in endocrinology

ea0081ap5.2 | European Hormone Medal Award Lecture | ECE2022

Diabetic kidney disease: after years of darkness came light – finally new options for treatment!

Rossing Peter

Unfortunately diabetes is a growing problem with now more than 537 million people worldwide having diabetes according to International Diabetes Federation. Excess morbidity and mortality in diabetes is related to the development of diabetic kidney disease seen in 30-40%, which not only causes end stage kidney disease, but also increases risk for cardiovascular events and mortality, which is the leading cause of death. Treatment of diabetic kidney disease has been control of gl...

ea0037s2.1 | Management of type 2 diabetes: State of the art | ECE2015

Blood pressure management in Type 2 Diabetes Mellitus

Rossing Peter

Hypertension is a major risk factor in type 2 diabetes both for cardiovascular and microvascular complications. It has been estimated that hypertension contributes to 41% of the attributable risk for mortality. Proper assessment of blood pressure, consideration of diurnal pattern, white coat and masked hypertension is important. Lifestyle factors should be addressed in the management, but in most patients pharmaceutical intervention is needed. The optimal intervention usually ...

ea0043oc9 | Cardiovascular Outcome Studies | WCTD2016

Years of Life Gained by Multifactorial Intervention in Patients with Type 2 Diabetes and Microalbuminuria – 21 Years Follow-Up on the Steno-2 Study

Ollgaard Jens , Gaede Peter , Carstensen Bendix , Rossing Peter , Lund-Andersen Henrik , Parving Hans-Henrik , Pedersen Oluf

Aims: To study the potential long-term impact of a 7.8 years intensified, multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria in terms of gained years of life and years free from incident cardiovascular disease.Methods: The original intervention (mean treatment duration 7.8 years) involved 160 patients with type 2 diabetes and microalbuminuria that were randomly assigned to either conventional therapy or intensified...

ea0059p084 | Diabetes & cardiovascular | SFEBES2018

Differential regulation of urinary peptides between men and women at early stages of diabetic nephropathy

Currie Gemma , von Scholten Bernt Johan , Lindhardt Morten , Mary Sheon , Mischak Harald , Rossing Peter , Delles Christian

Background: There are differences in the development of diabetic nephropathy (DN) between men and women but the underlying molecular mechanisms are unknown. The urinary proteome may contain sex-specific biomarkers and thereby identify differentially regulated pathways to DN in men and women.Method: Urine samples were obtained from 157 patients with type 2 diabetes (age, 61 (29–71) years; 120 men and 37 women), preserved renal function (eGFR, 88 &#17...

ea0073aep383 | Endocrine-Related Cancer | ECE2021

Paraganglioma of the basis cranii due to somatic mutations ind SDHB and PTEN genes

Main Ailsa Maria , Klose Marianne , Rasmussen Krogh , Loya Anand Chainsukh , Rossing Caroline Maria , Kistorp Thomas , Buch Kaare Fugleholm , Soelling Christine , Poulsgaard Lars , Benndorf Goetz , Feldt-Rasmussen Ulla

Head and neck paragangliomas (HNPGLs) are a type of neuroendocrine tumour. They arise from the sympathetic ganglia and can be either sporadic or due to hereditary syndromes (up to 40%). Most HNPGLs do not produce significant amounts of catecholamines1. Often, HNPGLs are detected in late stages due to compression or infiltration of cranial structures1. We report a case of a paraganglioma of the basis cranii due to somatic variants of SDHB (succinate dehydr...